AndroBioSys
Biotechnology company that focuses on the development of novel treatments for prostate disease.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD3—5m (Dealroom.co estimates Jan 2009.)
New York City New York (HQ)
Authorizing premium user...